Cirrhotic cardiomyopathy

Area of Science:

• Cardiology
• Hepatology
• Internal Medicine

Background:

• Decompensated liver cirrhosis presents with peripheral vasodilation and hyperdynamic circulation.
• This sustained cardiac workload can lead to heart abnormalities, termed "cirrhotic cardiomyopathy."
• Cirrhotic cardiomyopathy is characterized by increased cardiac output, impaired contractility, and altered response to stimuli.

Purpose of the Study:

• To describe the clinical entity of cirrhotic cardiomyopathy.
• To outline the cardiac abnormalities associated with liver cirrhosis.
• To identify conditions that may unmask latent cirrhotic cardiomyopathy.

Main Methods:

• Literature review and synthesis of existing research on cirrhotic cardiomyopathy.
• Analysis of clinical characteristics and hemodynamic changes in cirrhotic patients.
• Review of treatment interventions that impact cardiac function in cirrhosis.

Main Results:

• Cirrhotic cardiomyopathy often presents subclinically due to reduced afterload from vasodilation.
• Key features include increased cardiac output, defective myocardial contractility, and impaired beta-adrenergic function.
• Interventions like shunts or liver transplantation can increase preload, unmasking heart failure.

Conclusions:

• Cirrhotic cardiomyopathy is a distinct clinical entity in decompensated liver cirrhosis.
• The condition is often masked but can be revealed by interventions that alter hemodynamics.
• Recognizing and managing cirrhotic cardiomyopathy is crucial for cirrhotic patients undergoing certain treatments.